Skip to main content
HCPCS J3473 · Level II · Part B drug

J3473: hyaluronidase (Hylenex), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J3473

Billing unit
1 USP UNIT
Hyaluronidase recombinant
ASP payment limit
$0.364
October 2026; +0.0% vs July 2026
Practitioner MUE
450
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J3473 is the Level II code for Injection, hyaluronidase, recombinant, 1 usp unit, billed per 1 USP UNIT. The Medicare Part B ASP payment limit for October 2026 is $0.364 per billing unit, up 0.0% from July 2026. The practitioner MUE allows up to 450 units per date of service (MAI 3), so a full 450-unit day is $163.80 at the current limit. Under OPPS it carries status indicator N. J3473 is billed in units of 1 USP UNIT; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names hyaluronidase: J3470 (Amphadase from Amphastar Pharmaceuticals, Inc.; billed per 150 units). The ASP crosswalk maps 2 NDCs to it, sold as Hylenex by Antares Pharma, Inc., HF Acquisition Co. LLC, DBA HealthFirst. No current Billing and Coding Article lists J3473, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J3473 at $0.364 per 1 USP UNIT for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.364 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J3473
QuarterPayment limitPerCoinsurance
October 2026$0.3641 USP UNIT20%
July 2026$0.3641 USP UNIT—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 2 NDCs from 2 labelers to J3473. Report the NDC in the claim's drug segment and bill the number of J3473 units that equals the quantity administered divided by 1 USP UNIT; the last column gives units per full package.

NDCs that crosswalk to J3473
NDCDrug nameLabelerPackage sizeBilling units / package
18657-0117-04HylenexAntares Pharma, Inc.1 × 4600
51662-1555-01HylenexHF Acquisition Co. LLC, DBA HealthFirst1 × 1150

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J3473. For practitioners the limit is 450 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J3473 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services4503 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital4503 Date of Service Edit: ClinicalPrescribing Information
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J3473 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J3473 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J3473 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J3473 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J3473 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J3473 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J3473 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J3473 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J3473

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J3473

What does HCPCS code J3473 describe?

J3473 is defined by CMS as "Injection, hyaluronidase, recombinant, 1 usp unit". Each billing unit represents 1 USP UNIT, so the units reported on the claim must equal the dose administered divided by that unit.

Is J3473 a CPT code?

No. J3473 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as hyaluronidase (Hylenex); CPT codes are five-character codes maintained by the AMA. On a Part B claim J3473 reports the drug itself in 1 usp unit units, and the administration is billed on its own line.

What is the Medicare reimbursement for J3473 in October 2026?

The ASP-based payment limit is $0.364 per 1 USP UNIT, with 20% beneficiary coinsurance. The July 2026 limit was $0.364. Commercial payers use their own fee schedules.

How many units of J3473 can be billed per day?

The practitioner Medically Unlikely Edit is 450 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J3473?

The October 2026 ASP crosswalk lists 2 NDCs from 2 labelers: Hylenex (Antares Pharma, Inc.); Hylenex (HF Acquisition Co. LLC, DBA HealthFirst). For example NDC 18657-0117-04 (package size 1) equals 600 billing units of J3473.

Does J3473 have NCCI bundling edits?

No active practitioner PTP pairs list J3473 as a column-1 or column-2 code in the v323r0 release.

J3473 vs J3470: what is the difference?

Both are HCPCS Level II codes whose descriptor names hyaluronidase. What sets J3470 apart: Amphadase from Amphastar Pharmaceuticals, Inc.; billed per 150 units. J3473 is billed per 1 usp unit, limit $0.364, MUE 450; J3470 is billed per 150 units, limit $31.802, MUE 3. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.